AXGN: AxoGen, Inc. Forward P/E Multiple

Graphic logo of axogeninc.com (AXGN)

The future P/E ratio of AxoGen, Inc. (AXGN) correlates with environmental measures to reduce energy consumption and waste. The latest parameter stands at 71.70, complemented by strict adherence to biomaterial disposal standards and the minimization of plastics. The financial success of AxoGen, Inc. (AXGN) is based on the sale of protective conduits and Avance nerve grafts for peripheral nerve regeneration.

axogeninc.com - AXGN Price to Expected Earnings Ratio (period 07/04/2022 - 11/10/2026)
Brand item of axogeninc.com

Forward P/E is calculated as the ratio of the current share price to projected earnings based on analyst consensus estimates. This metric allows for the differentiation of short-term speculation from fundamental growth by eliminating the lag between reports. For AxoGen, Inc. (AXGN), this calculation is critical due to its narrow specialization in nerve regeneration. Market expectations regarding the expanded application of matrices directly influence the company's expected P/E level. A sharp increase in this ratio signals a high premium for its pioneer status but increases the risk of a correction in the event of operational disruptions.

Competitors of AxoGen, Inc.

Future Price to Earnings Boston Scientific Corporation (BSX)|Future Price to Earnings EW (Edwards)|Forward P/E Multiple RMD (ResMed Corp)|Market Cap to Projected Earnings Insulet Inc. (PODD)|ZBH: Projected Price to Earnings|Price to Expected Earnings Ratio COO|ALGN: Forward P/E Multiple|Projected Price to Earnings Ratio Globus Medical Inc (GMED)|TMDX (TransMedics Group) - Forward P/E Multiple|Price to Future Earnings Ratio ATEC (Alphatec Corp)|Projected Price to Earnings AORT (Artivion, Inc.)|ENOV (enovis.com) - Future Price to Earnings Multiple|Future Price to Earnings Integra LifeSciences Holdings Corporation IART|ESTA - Projected Price to Earnings|Beta Bionics Corp - Forward P/E Multiple|Projected Price to Earnings Ratio IRADIMED Inc.|EMBC: Forward P/E Multiple|Price to Future Earnings Ratio TNDM|SIBN (SI-BONE) - Forward P/E Multiple|Orthofix Medical (OFIX) - Market Cap to Projected Earnings|Forward P/E Multiple BVS|Projected Price to Earnings orthopediatrics.com KIDS|Forward P/E Multiple TMCI (Treace Medical Concepts)|Forward P/E Multiple blade.com SRTA|CARL - Future Price to Earnings|RXST: Future Price to Earnings|CLPT (clearpointneuro.com) - Projected Price to Earnings|Stereotaxis Corporation - Future Price to Earnings Multiple|STIM (Neuronetics, Inc.) - Forward P/E Multiple|Projected Price to Earnings Ratio sightsciences.com SGHT|Future Price to Earnings Orchestra BioMed, Inc. (OBIO)|anikatherapeutics.com (ANIK) - Forward Price to Earnings Multiple|InspireMD Corp - Projected Price to Earnings|Forward P/E Multiple Jin Medical International Ltd. ZJYL|Vivani - Forward P/E Multiple|Market Cap to Projected Earnings Xtant Medical Holdings XTNT|NeuroOne Medical Technologies Corporation (NMTC) - Future Price to Earnings|Price to Expected Earnings Ratio MODD (Modular Medical, Inc.)|Future Price to Earnings Myomo, Inc|Projected Price to Earnings Envoy Medical Inc (COCH)|Forward P/E Multiple VVOS|NVNO - Projected Price to Earnings Ratio|Future Price to Earnings Sintx Technologies, Inc. SINT|TNON: Price to Future Earnings Ratio|LFWD: Projected Price to Earnings|Autonomix Medical, Inc. - Market Cap to Future Earnings Ratio|IVF: Forward P/E Multiple|bonebiologics.com (BBLG) - Forward P/E Multiple|Projected Price to Earnings AXNX|Price to Future Earnings Ratio BIOL (BIOLASE Inc.)|Future Price to Earnings Dynatronics Corporation (DYNT)|FNA - Projected Price to Earnings Ratio|Forward P/E Multiple INVO (INVO Bioscience)